{"id":19785,"date":"2023-09-05T08:51:58","date_gmt":"2023-09-05T06:51:58","guid":{"rendered":"https:\/\/ggba.swiss\/?p=19785"},"modified":"2023-09-05T08:51:59","modified_gmt":"2023-09-05T06:51:59","slug":"ten23-health-boosts-sterile-production-capacity-and-introduces-new-quality-control-services","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/en\/ten23-health-boosts-sterile-production-capacity-and-introduces-new-quality-control-services\/","title":{"rendered":"ten23 health boosts sterile production capacity and introduces new quality control services"},"content":{"rendered":"\n

In a recent update, ten23 health<\/a> unveiled its plan to launch \u201cquality control\u201d (QC) service offerings in Switzerland. These services will focus on the release and stability testing of both clinical and commercial sterile drug products, adhering to international cGMP standards. With this expansion, both Basel and Visp sites are looking at a promising potential for job growth in the near future.<\/p>\n\n\n\n

The division of services is clear – Basel will focus on physico-chemical testing, ensuring the release and stability of sterile, pharmaceutical Drug Products. In Visp (canton of Valais), the emphasis will be on microbiological quality control services. This includes monitoring environmental factors and final product microbiological testing, complementing their ongoing expansion of the sterile product manufacturing capacity.<\/p>\n\n\n\n

ten23 health has been proactive in this venture, having already brought in experts for these QC services. The company is confident and aims to have these services operational and GMP ready by Q2 of 2024. Hanns-Christian Mahler, CEO of ten23 health, expressed his enthusiasm, “By adding these services, we aim to streamline the development, testing, and manufacturing processes for our clients. Our expanded offerings will undoubtedly offer immense value, driving the success of their pharmaceutical endeavors.”<\/p>\n\n\n\n

50% boost in sterile production at the BioArk site in Visp<\/h4>\n\n\n\n

In a separate announcement, the company shared its plans to augment its sterile production capacity by a substantial 50% at its site on the BioArk<\/a> park in Visp. The initiative will fulfill the escalating demand for filling and finishing services for sterile products. This expansion follows their recent declaration of increasing storage space and visual inspection capabilities, set to be operational by September 2023 after a successful GMP inspection.<\/p>\n\n\n\n

Moreover, with two additional filling lines under construction, named VIVA 2, the company continues to solidify its position as a leader in sterile manufacturing. A partnership for a customer project and technology transfer slated for 2024 and 2025 has already been secured.<\/p>\n\n\n\n

Prof. Dr. Hanns-Christian Mahler summarized the company’s aspirations, “Our customers are eager to leverage the increased capacity of the existing VIVA 1\u00ae facility, before the introduction of the larger VIVA 2\u00ae plant. With the surge in demand, we\u2019re well-poised to deliver.”<\/p>\n\n\n\n

These developments, in conjunction with their recent expansion in Visp<\/a>, emphasize ten23 health’s commitment to innovation and excellence in the realm of pharmaceutical services.<\/p>\n","protected":false},"excerpt":{"rendered":"

Renowned for its expertise in sterile drug product manufacturing, Valais-based ten23 health is taking significant steps to expand its services and capabilities.<\/p>\n","protected":false},"author":6,"featured_media":19786,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[833],"tags":[918,963,926],"class_list":["post-19785","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-life-science","tag-investment","tag-medical-devices","tag-medtech"],"acf":[],"yoast_head":"\nten23 health boosts production capacity and quality control services<\/title>\n<meta name=\"description\" content=\"At its site at the BioArk in Visp, ten23 health is taking significant steps to expand its services and capabilities.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ggba.swiss\/en\/ten23-health-boosts-sterile-production-capacity-and-introduces-new-quality-control-services\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ten23 health boosts production capacity and quality control services\" \/>\n<meta property=\"og:description\" content=\"At its site at the BioArk in Visp, ten23 health is taking significant steps to expand its services and capabilities.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ggba.swiss\/en\/ten23-health-boosts-sterile-production-capacity-and-introduces-new-quality-control-services\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2023-09-05T06:51:58+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-09-05T06:51:59+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ggba.swiss\/app\/uploads\/2023\/09\/Visp-Ten23-health-Valais4You-1180x811-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1180\" \/>\n\t<meta property=\"og:image:height\" content=\"811\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Pierre-Yves Oehrli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pierre-Yves Oehrli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ggba.swiss\/en\/ten23-health-boosts-sterile-production-capacity-and-introduces-new-quality-control-services\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ggba.swiss\/en\/ten23-health-boosts-sterile-production-capacity-and-introduces-new-quality-control-services\/\"},\"author\":{\"name\":\"Pierre-Yves Oehrli\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"headline\":\"ten23 health boosts sterile production capacity and introduces new quality control services\",\"datePublished\":\"2023-09-05T06:51:58+00:00\",\"dateModified\":\"2023-09-05T06:51:59+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/en\/ten23-health-boosts-sterile-production-capacity-and-introduces-new-quality-control-services\/\"},\"wordCount\":388,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/ggba.swiss\/en\/ten23-health-boosts-sterile-production-capacity-and-introduces-new-quality-control-services\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/09\/Visp-Ten23-health-Valais4You-1180x811-1.png\",\"keywords\":[\"Investment\",\"Medical Devices\",\"Medtech\"],\"articleSection\":[\"Life sciences\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/ggba.swiss\/en\/ten23-health-boosts-sterile-production-capacity-and-introduces-new-quality-control-services\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ggba.swiss\/en\/ten23-health-boosts-sterile-production-capacity-and-introduces-new-quality-control-services\/\",\"url\":\"https:\/\/ggba.swiss\/en\/ten23-health-boosts-sterile-production-capacity-and-introduces-new-quality-control-services\/\",\"name\":\"ten23 health boosts production capacity and quality control services\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/en\/ten23-health-boosts-sterile-production-capacity-and-introduces-new-quality-control-services\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ggba.swiss\/en\/ten23-health-boosts-sterile-production-capacity-and-introduces-new-quality-control-services\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/09\/Visp-Ten23-health-Valais4You-1180x811-1.png\",\"datePublished\":\"2023-09-05T06:51:58+00:00\",\"dateModified\":\"2023-09-05T06:51:59+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"description\":\"At its site at the BioArk in Visp, ten23 health is taking significant steps to expand its services and capabilities.\",\"breadcrumb\":{\"@id\":\"https:\/\/ggba.swiss\/en\/ten23-health-boosts-sterile-production-capacity-and-introduces-new-quality-control-services\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ggba.swiss\/en\/ten23-health-boosts-sterile-production-capacity-and-introduces-new-quality-control-services\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ggba.swiss\/en\/ten23-health-boosts-sterile-production-capacity-and-introduces-new-quality-control-services\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/09\/Visp-Ten23-health-Valais4You-1180x811-1.png\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/09\/Visp-Ten23-health-Valais4You-1180x811-1.png\",\"width\":1180,\"height\":811,\"caption\":\"ten23 Health, known for its commitment to delivering high-quality pharmaceutical services from its sites in Basel and BioArk in Visp, has recently made two major announcements which are set to make waves in the pharmaceutical sector. | \u00a9 Valais4you\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ggba.swiss\/en\/ten23-health-boosts-sterile-production-capacity-and-introduces-new-quality-control-services\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ten23 health boosts sterile production capacity and introduces new quality control services\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\",\"name\":\"Pierre-Yves Oehrli\",\"url\":\"https:\/\/ggba.swiss\/en\/author\/pierre-yves-oehrli\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ten23 health boosts production capacity and quality control services","description":"At its site at the BioArk in Visp, ten23 health is taking significant steps to expand its services and capabilities.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ggba.swiss\/en\/ten23-health-boosts-sterile-production-capacity-and-introduces-new-quality-control-services\/","og_locale":"en_US","og_type":"article","og_title":"ten23 health boosts production capacity and quality control services","og_description":"At its site at the BioArk in Visp, ten23 health is taking significant steps to expand its services and capabilities.","og_url":"https:\/\/ggba.swiss\/en\/ten23-health-boosts-sterile-production-capacity-and-introduces-new-quality-control-services\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2023-09-05T06:51:58+00:00","article_modified_time":"2023-09-05T06:51:59+00:00","og_image":[{"width":1180,"height":811,"url":"https:\/\/ggba.swiss\/app\/uploads\/2023\/09\/Visp-Ten23-health-Valais4You-1180x811-1.png","type":"image\/png"}],"author":"Pierre-Yves Oehrli","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Pierre-Yves Oehrli","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ggba.swiss\/en\/ten23-health-boosts-sterile-production-capacity-and-introduces-new-quality-control-services\/#article","isPartOf":{"@id":"https:\/\/ggba.swiss\/en\/ten23-health-boosts-sterile-production-capacity-and-introduces-new-quality-control-services\/"},"author":{"name":"Pierre-Yves Oehrli","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"headline":"ten23 health boosts sterile production capacity and introduces new quality control services","datePublished":"2023-09-05T06:51:58+00:00","dateModified":"2023-09-05T06:51:59+00:00","mainEntityOfPage":{"@id":"https:\/\/ggba.swiss\/en\/ten23-health-boosts-sterile-production-capacity-and-introduces-new-quality-control-services\/"},"wordCount":388,"commentCount":0,"image":{"@id":"https:\/\/ggba.swiss\/en\/ten23-health-boosts-sterile-production-capacity-and-introduces-new-quality-control-services\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/09\/Visp-Ten23-health-Valais4You-1180x811-1.png","keywords":["Investment","Medical Devices","Medtech"],"articleSection":["Life sciences"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ggba.swiss\/en\/ten23-health-boosts-sterile-production-capacity-and-introduces-new-quality-control-services\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ggba.swiss\/en\/ten23-health-boosts-sterile-production-capacity-and-introduces-new-quality-control-services\/","url":"https:\/\/ggba.swiss\/en\/ten23-health-boosts-sterile-production-capacity-and-introduces-new-quality-control-services\/","name":"ten23 health boosts production capacity and quality control services","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ggba.swiss\/en\/ten23-health-boosts-sterile-production-capacity-and-introduces-new-quality-control-services\/#primaryimage"},"image":{"@id":"https:\/\/ggba.swiss\/en\/ten23-health-boosts-sterile-production-capacity-and-introduces-new-quality-control-services\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/09\/Visp-Ten23-health-Valais4You-1180x811-1.png","datePublished":"2023-09-05T06:51:58+00:00","dateModified":"2023-09-05T06:51:59+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"description":"At its site at the BioArk in Visp, ten23 health is taking significant steps to expand its services and capabilities.","breadcrumb":{"@id":"https:\/\/ggba.swiss\/en\/ten23-health-boosts-sterile-production-capacity-and-introduces-new-quality-control-services\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ggba.swiss\/en\/ten23-health-boosts-sterile-production-capacity-and-introduces-new-quality-control-services\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ggba.swiss\/en\/ten23-health-boosts-sterile-production-capacity-and-introduces-new-quality-control-services\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2023\/09\/Visp-Ten23-health-Valais4You-1180x811-1.png","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/09\/Visp-Ten23-health-Valais4You-1180x811-1.png","width":1180,"height":811,"caption":"ten23 Health, known for its commitment to delivering high-quality pharmaceutical services from its sites in Basel and BioArk in Visp, has recently made two major announcements which are set to make waves in the pharmaceutical sector. | \u00a9 Valais4you"},{"@type":"BreadcrumbList","@id":"https:\/\/ggba.swiss\/en\/ten23-health-boosts-sterile-production-capacity-and-introduces-new-quality-control-services\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/en\/"},{"@type":"ListItem","position":2,"name":"ten23 health boosts sterile production capacity and introduces new quality control services"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41","name":"Pierre-Yves Oehrli","url":"https:\/\/ggba.swiss\/en\/author\/pierre-yves-oehrli\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/19785","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/comments?post=19785"}],"version-history":[{"count":2,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/19785\/revisions"}],"predecessor-version":[{"id":19790,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/19785\/revisions\/19790"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/media\/19786"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/media?parent=19785"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/categories?post=19785"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/tags?post=19785"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}